Jessica Skarzynski | Authors


Oral Paclitaxel, Encequidar Combo Associated with Improved Efficacy, Lower Neuropathy Rates in mBC

December 10, 2020

Treatment with the combination of oral paclitaxel and encequidar was found to be associated with greater efficacy in patients with metastatic breast cancer, as well as lower rates of chemotherapy-induced peripheral neuropathy, compared to intravenous paclitaxel.

Carfilzomib Triplet Fails to Induce Superior PFS in Newly Diagnosed Multiple Myeloma

May 29, 2020

Carfilzomib combined with lenalidomide and dexamethasone failed to improve progression-free survival, compared with the current standard of care triplet of bortezomib, lenalidomide, and dexamethasone, in patients with newly diagnosed multiple myeloma.